CWBHF - Charlotte's Web Holdings, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
13.57
+0.68 (+5.31%)
As of 10:47AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close12.89
Open12.96
Bid0.00 x 0
Ask0.00 x 0
Day's Range12.58 - 13.58
52 Week Range8.13 - 25.25
Volume198,003
Avg. Volume400,535
Market Cap1.295B
Beta (3Y Monthly)N/A
PE Ratio (TTM)134.40
EPS (TTM)0.10
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est23.92
Trade prices are not sourced from all markets
  • CNW Group3 hours ago

    Charlotte's Web Announces 187% Increase in Hemp Acres Planted for 2019

    BOULDER, CO , June 19, 2019 /CNW/ - Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") (TSX:CWEB, OTCQX:CWBHF), the market leader in hemp CBD extract products , today reported final hemp planting for its 2019 growing season. In 2016, 2017 and 2018, the Company produced 41,000 lbs., 63,000 lbs. and 675,000 lbs., respectively, of dried hemp biomass.

  • Marijuana Value Stocks Do Exist: Here Are 3 to Consider Buying
    Motley Foolyesterday

    Marijuana Value Stocks Do Exist: Here Are 3 to Consider Buying

    These pot stocks have a lower forward price-to-earnings ratio than the broad-based S&P 500.

  • 3 Medical Marijuana Stocks to Buy
    InvestorPlace5 days ago

    3 Medical Marijuana Stocks to Buy

    [Editor's note: This story was previously published in March 2019. It has since been updated and republished.]Often, when analysts or bloggers talk up the potential of marijuana stocks, the focus is on the consumer side of the industry. But some of the best stocks in the pot sector may be medical marijuana stocks.Indeed, it's on the medical side where growth likely is to be largest in the near term. Canada did legalize recreational marijuana in October, but investors promptly sold the news in response. U.S. legalization is likely to be a long slog. Attitudes are mixed in Europe -- but even in legalized markets anywhere, black market (and untaxed) operators will be able to take share.InvestorPlace - Stock Market News, Stock Advice & Trading TipsMeanwhile, approval of medical marijuana (in the U.S. and elsewhere) seems to be moving at a faster pace. In such a highly regulated market, black market and even smaller producers likely will be shut out. Quality and consistency will be key. Here, scale will matter. And those companies that win early have the best chance of becoming market leaders -- and providing big gains for investors. * 10 Stocks to Buy That Wall Street Expects to Soar for the Rest of 2019 As always -- and particularly in this space -- investors need to mind the risks and size positions accordingly. But for investors who see medical marijuana stocks as the next big thing, these three are the best stocks to buy for investors enamored with weed.Source: Shutterstock Charlotte's Web (CWBHF)Charlotte's Web (OTCMKTS:CWBHF) has become one of the leading players in CBD oil (cannabidiol). And though Charlotte's Web products are made from hemp -- at least for now -- instead of marijuana, the stock still looks like one of the best plays in the sector.InvestorPlace's Matt McCall named CWBHF (the stock also trades on the Canadian Securities Exchange, ticker CWEB) as his pick for our list of the best stocks for 2019. And the case makes some sense. CBD oil sales are soaring, and Charlotte's Web is a market leader. As McCall pointed out, the federal farm bill in the U.S. provided a catalyst by legalizing hemp.With so many customers yet to try CBD oil -- and so many existing users attached -- market growth should be huge. And while CWBHF isn't cheap from a valuation standpoint, its position as a market leader should allow it to grow into its valuation.Source: Shutterstock Cronos (CRON)Of late, marijuana producer Cronos Group (NASDAQ:CRON) has made the headlines for its consumer business. Most recently, tobacco giant Altria (NYSE:MO) invested some $1.8 billion in the company. The combination of Altria's advertising and distribution reach and Cronos' production capabilities would seem to be the best fit for the consumer side of the business.But investors can't ignore that Cronos is a medical marijuana stock as well. In fact, it's that business that drives the majority of its revenue at the moment. And it also has given the company a beachhead in multiple markets around the world, from its home market of Canada to Germany, Israel and Poland. * 10 Stocks to Buy That Wall Street Expects to Soar for the Rest of 2019 I wrote after the Altria deal that investors should stay patient with CRON stock. And in this market, that might still be wise advice.Source: Shutterstock CannTrust (CTST)CannTrust (NYSE:CTST) has been one of the biggest victims of the post-legalization selloff. The stock lost more than half its value and touched a 52-week low in the process last year. And it's been in an almost continuous slump again since March.Unlike many peers, the company usually posts gross profits. And its established leadership in the Canadian medical marijuana industry should drive consistent growth and allow CannTrust to stay profitable. There is some retail exposure here as well, but unlike peers, CannTrust seems to have room to drive upside on the medical side alone.CannTrust also was able to get a listing on the New York Stock Exchange this year. Admittedly, uplisting hasn't helped pot stocks in and of itself (most notably Aurora Cannabis (NYSE:ACB) took a lot longer to take off than was expected), but it certainly didn't hurt.From a profitability standpoint, at least, CNNTF seems like one of the best stocks in the pot sector. And with valuation near the lows, at least some of the risks here likely are priced in.As of this writing, Vince Martin has no positions in any securities mentioned. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 10 Stocks to Buy That Wall Street Expects to Soar for the Rest of 2019 * 7 Value Stocks That Are Flying Under the Radar * 6 Mouth-Watering Fast Food Stocks for Growth Investors Compare Brokers The post 3 Medical Marijuana Stocks to Buy appeared first on InvestorPlace.

  • CBD leader CV Sciences jumps 10% on Kroger deal to sell CBD oil in 17 US states
    Yahoo Finance7 days ago

    CBD leader CV Sciences jumps 10% on Kroger deal to sell CBD oil in 17 US states

    Shares of CBD company CV Sciences jumped 10% on a deal with retailer Kroger to sell its oils in nearly 1,000 stores.

  • 3 Top Cannabis Stocks for June 2019
    SmarterAnalyst13 days ago

    3 Top Cannabis Stocks for June 2019

    June 2019 might hold some surprises for cannabis stocks. With the recent market downtrend, there are many great cannabis stocks potentially selling at a discount. It's become evident that cannabis is now consolidating and potentially setting up for the next wave of volatility. Whether that wave proves to be bullish or not is yet to be determined. For June 2019, there are a few stocks worth watching.Here is a short list of stocks to look out for June: Charlotte's Web Holdings (CWBHF)Charlotte’s Web, one of the leaders in hemp CBD extract products, is a new listing with incredible potential. It’s business model focuses mostly on hemp CBD products. Non-intoxicating and highly effective at improving health among many other uses, hemp is revolutionizing many industries. Charlotte’s Web is one of those companies leading the hemp revolution with CBD pet products, CBD capsules and extracts, and a wide range of other products. Although not considered technically ‘cannabis’, hemp has become an incredibly powerful movement in American agriculture.Hemp stocks in general are an interesting play. They offer a great alternative to purely cannabis stocks and give opportunity for investors in America to get into the cannabis market in some form. Hemp provides incredible value in the form of textiles, CBD, protein products, general nutrition (hemp seeds) and more. Charlotte’s Web is one of the companies leading the hemp revolution. So look out!In late April, Benchmark analyst Mike Hickey initiated coverage on Charlotte's Web's stock, with a Buy rating and a $25 price target, which is nearly 100% upside from current trading level.Hickey opined, "Our positive view on CWEB is based on the Company’s exposure to meaningful demand drivers that include: 1) Early leadership and brand development in the rapidly emerging domestic CBD market, which could reach $22B in 2022; 2) Recent passage of the 2018 Farm Bill where hemp is removed from the Controlled Substances Act and removed from the jurisdiction of the Drug Enforcement Agency (DEA); 3) A vertically integrated business model with a significant 2018 hemp harvest. CWEB has established manufacturing and distribution capabilities, all of which sets the stage for accelerating near term business growth; 4) Continued rapid expansion of CWEB’s product retail locations including national chains and growth from its ecommerce platform; 5) Ongoing brand development and product innovations that deliver CBD as the active ingredient. Anticipated new product offerings include consumables, pet offerings and differentiated topicals / cosmetics." Canopy Growth (CGC)Canopy Growth is also doing interesting things. Similar to Charlotte’s Web, it sees incredible potential in the current hemp market in the U.S.. It’s one of the first Canadian cannabis producers to enter the hemp CBD market and has large plans to expand that part of its business. Canopy is also highly invested in cannabis products such as edibles and beverages making is a very interesting company to look out for before Canada opens its doors to edibles later this year.GMP analyst Martin Landry recently reiterated a Buy rating on Canopy stock, with a C$72 price target, suggesting the stock can rise 30% from current levels.Landry noted, "The BC greenhouses appear to be running smoothly across all areas of production, trimming and drying. We value Canopy using a sum-of-the-parts with pro-forma share count assuming the Acreage acquisition closes. We value Acreage at 22x consensus 2021 EBITDA of US$292m for a value of $15.00 per pro-forma share. Our valuation of Canopy’s legacy operations is unchanged at $31b (or $56.00 using a pro-forma share count) and derived using a DCF calculation with the following: 1) a 7.5% discount rate, 2) a 28% share of the recreational market, (3) a 28% EBITDA margin, and (4) a 3.2% terminal growth."Overall, Canopy has had 7 bullish analysts in its corner over the last three months, and 4 analysts playing it safe on the sidelines. Importantly, the 12-month average price target of C$80.17 showcases 46% in upside potential for the stock. Namaste Technologies (NXTTF)Namaste stock is a love/hate relationship for many investors. It’s had a ‘journey’ of sorts trying to find its footing in the industry. Slowly consolidating after a bumpy ride from 3.74 in Oct 2018 to 0.88 for the last trading day of May 2019, it’s finally gaining a slight uptrend recently. Steadily trying to find its ground through all the adversity, Namaste may potentially be gearing back up to its former glory. June might see Namaste finally get its grip on the market.Bottom LineHemp stocks might have great potential in the next few months. Especially with the increasing social media hype and trade war. Canada itself is having issues with China and has had to cut exports of canola to China. Many farmers might start to replace those crops with hemp. So keep a look out for companies like Charlotte’s Web and Canopy. Tech might also start to rebound. Namaste has had a rough few months but is really well positioned in the cannabis space as a tech company and not a producer. Diversification is key and these three stocks provide different opportunities in the cannabis sector.To read more on the nitty gritty of what’s going on in the rising cannabis industry, click here.Disclosure: The author is Long NXTTF. Read more on the stocks mentioned: * Marijuana Stock Charlotte’s Web Looks Appealing at Current Levels * Cracks Are Forming in Canopy Growth (CGC) Stock * Namaste Technologies Stock Should Enjoy a Bright Future More recent articles from Smarter Analyst: * Hexo: When the Bulls Aren’t Bullish Enough * Market Delays Can Derail Aurora Cannabis (ACB) Stock * Canopy Growth (CGC): The Emperor Isn't Wearing Any Clothes * Nvidia (NVDA): A Real Lift or a Dead Cat Bounce?

  • OTC Markets Group Launches OTCQX Cannabis Index
    PR Newswire15 days ago

    OTC Markets Group Launches OTCQX Cannabis Index

    NEW YORK , June 4, 2019 /PRNewswire/ --  OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index ...

  • CNW Group16 days ago

    Charlotte's Web Announces Hemp Extract CBD Gummies for Calming, Recovery, and Sleep

    BOULDER, CO , June 3, 2019 /CNW/ - Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") (TSX:CWEB, OTCQX:CWBHF), the market leader in hemp CBD extract products, has officially unveiled its newest CBD product line - hemp extract-infused CBD Gummies – made with whole-plant extract from its prized hemp genetics and featuring synergistic functional ingredients to support specific health related functions including everyday stress, sleep, and recovery from exercise or active lifestyles. Available in a variety of flavors, gummies are the latest addition to the Company's expanding line of CBD hemp-extract products.

  • Charlotte's Web Commences Trading on the Toronto Stock Exchange Under Stock Ticker "CWEB"
    PR Newswire19 days ago

    Charlotte's Web Commences Trading on the Toronto Stock Exchange Under Stock Ticker "CWEB"

    BOULDER, CO, May 31, 2019 /PRNewswire/ - Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") (TSX:CWEB, OTCQX:CWBHF), the market leader in hemp CBD extract products, confirms commencement of  trading of the Company's common shares (the "Common Shares") on the Toronto Stock Exchange (the "TSX") effective today, Friday May 31, 2019 under the stock ticker "CWEB". In conjunction with listing on the TSX, the Common Shares were voluntarily delisted from the Canadian Securities Exchange (the "CSE") as at the close of trading yesterday, Thursday, May 30, 2019.

  • Cannabis stocks fall in step with broader market as latest earnings fail to impress
    MarketWatch20 days ago

    Cannabis stocks fall in step with broader market as latest earnings fail to impress

    Cannabis stocks fell Wednesday, weighed down by weakness in the broader markets and disappointment about some of the latest earnings from the sector.

  • 6 Things You Overlooked in Pot Stock Charlotte's Web's First-Quarter Report
    Motley Fool20 days ago

    6 Things You Overlooked in Pot Stock Charlotte's Web's First-Quarter Report

    The headline numbers simply don't tell the full story.

  • Charlotte's Web: 5 Facts About Its Latest Quarterly Results
    Motley Fool20 days ago

    Charlotte's Web: 5 Facts About Its Latest Quarterly Results

    Sales are soaring at this marijuana stock, but rising revenue isn't the only thing you should know about its performance last quarter.

  • Charlotte’s Web Holdings’ Q1 Earnings: Key Takeaways
    Market Realist21 days ago

    Charlotte’s Web Holdings’ Q1 Earnings: Key Takeaways

    Charlotte’s Web Holdings' Q1 Earnings: Key TakeawaysCharlotte’s Web HoldingsCharlotte’s Web Holdings (CWBHF) released its first-quarter earnings yesterday after the markets closed. The company reported revenues of $21.7 million in the quarter.

  • CNW Group21 days ago

    Charlotte's Web Announces TSX Listing

    BOULDER, CO , May 29, 2019 /CNW/ - Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") (CSE:CWEB, OTCQX:CWBHF), the market leader in hemp CBD extract products, is pleased to announce that it has received conditional approval for the listing of the Company's common shares (the "Common Shares") on the Toronto Stock Exchange (the "TSX").

  • MarketWatch22 days ago

    CBD maker Charlotte's Web revenue grows 66% in first quarter

    Charlotte's Web Holdings Inc. reported shrinking profits and a 66% increase in revenue compared with the year-ago period when the cannabidiol, or CBD, product maker issued earnings late Tuesday. The company reported first-quarter net income of $2.3 million, or 2 cents a share, compared with $3.1 million, or 4 cents a share, in the year-ago period. Revenue rose to $21.7 million from $13.1 million in the year-ago period. FactSet does not report enough earnings and revenue estimates from analysts to form a reliable consensus figure. Charlotte's Web reiterated its full-year revenue guidance of $120 million to $170 million. Charlotte's Web stock has gained 20% in the past six months, with the S&P 500 index rising 3%.

  • PR Newswire22 days ago

    Charlotte's Web Holdings Reports 2019 Q1 Earnings

    Q1 revenue increases 66% YoY to US$21.7 million Adjusted EBITDA of $4.5 million and US$0.03 EPS BOULDER, CO , May 28, 2019 /PRNewswire/ - Charlotte's Web Holdings, Inc. ("Charlotte's Web" or ...

  • 3 Marijuana Stocks Set to Uplist to the NYSE or Nasdaq in 2019
    Motley Fool22 days ago

    3 Marijuana Stocks Set to Uplist to the NYSE or Nasdaq in 2019

    These pot stocks are ready for a move into the prime time.

  • Analyzing Charlotte’s Web Holdings’ Q1 Earnings Estimates
    Market Realist23 days ago

    Analyzing Charlotte’s Web Holdings’ Q1 Earnings Estimates

    Analyzing Charlotte’s Web Holdings’ Q1 Earnings EstimatesCharlotte’s Web HoldingsCharlotte’s Web Holdings (CWBHF) is scheduled to release its first-quarter earnings tomorrow and hold its earnings conference call on Wednesday. Cresco Labs’

  • CNW Group26 days ago

    Charlotte's Web Announces Exercise of Over-Allotment Option in connection with Underwritten Secondary Offering of Common Shares

    BOULDER, CO , May 24, 2019 /CNW/ - (CSE:CWEB, OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market share leader in hemp-derived CBD extract products, is pleased to announce today that the Underwriters (as defined below) of its previously-announced underwritten public offering of 7,000,000 common shares of the Company sold by certain current shareholders (the "Selling Shareholders") at a price of C$20.00 per share (the "Offering Price") have exercised in full their option to purchase an additional 1,050,000 common shares from the Selling Shareholders at the Offering Price. The gross proceeds to the Selling Shareholders under the exercise of this over-allotment will be C$21,000,000 , and together with the gross proceeds from the initial closing on May 15, 2019 of C$140,000,000 , the aggregate gross proceeds of the offering (the "Offering") will be $161,000,000 .

  • How Cresco Labs Stacks Up against Other Cannabis Players
    Market Realist27 days ago

    How Cresco Labs Stacks Up against Other Cannabis Players

    How Cresco Labs Stacks Up against Other Cannabis PlayersCresco LabsCresco Labs (CRLBF) is a multistate cannabis company that has presences in both the adult use and medical cannabis markets. The company has its own production and distribution

  • Charlotte’s Web Holdings’ Returns Compared to Its Peers’
    Market Realist29 days ago

    Charlotte’s Web Holdings’ Returns Compared to Its Peers’

    Charlotte’s Web Holdings’ Returns Compared to Its Peers'Charlotte’s Web HoldingsThe cannabis space has seen a lot of investor interest over the last few quarters. We’ve also seen some new listings in the cannabis sector. Looking at the YTD